Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Scientific Officer
-
Stock Symbol
-
ATHA on Nasdaq
Kevin Church - trading volume in the past year for Athira Pharma, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Restricted Stock Units |
110K |
$62.3K |
$0.57 |
Oct 1, 2024 |
Direct |
Common Stock |
|
| Common Stock |
92.7K |
$52.5K |
$0.57 |
Sep 5, 2024 |
Direct |
|
|
| Stock Option (Right to Buy) |
110K |
|
|
Oct 1, 2024 |
Direct |
Common Stock |
|
Transactions reported by Kevin Church for Athira Pharma, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.